...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: otc zen

just can't seem to be able to wrap my head around the brutal sp & the terrible trading volume on this thing? Based on previous PP's along with the success so far & given who there collaborating with at this time , how can this be?

 

 

 

Share
New Message
Please login to post a reply